The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Changes of Intestinal Functions in Liver Cirrhosis
Open accessAbstract
Background: Understanding of the gut-liver axis is important for the up-to-date management of liver cirrhosis, and changes of intestinal functions form the core of this interesting research field. Summary: Most investigators noted small intestinal dysmotility in their patients with liver cirrhosis. Marked changes in the contraction pattern were observed in early manometric studies. The orocecal transit time, particularly small intestinal transit, has generally been reported to be prolonged, which has been demonstrated in multiple investigations to be related to the severity of the liver disease (e.g., Child-Pugh class), the presence of small intestinal bacterial overgrowth (SIBO) and hepatic encephalopathy (HE) as well as a history of spontaneous bacterial peritonitis. Bacteriologically proven SIBO in proximal jejunal aspiration has been reported to be present in up to 59% of cirrhotic patients and is associated with systemic endotoxemia. Clinical and experimental studies suggest that delayed small bowel transit in liver cirrhosis may lead to SIBO, which could contribute to the symptoms of abdominal pain and diarrhea. In addition to autonomic neuropathy, metabolic derangements and diabetic state, SIBO itself may delay intestinal transit in cirrhotic patients. Several studies, both from the West and the East, have shown that the gut microbiota is altered in cirrhotic patients and particularly those with HE. Further, a quantitative change in Bacteroides/Firmicutes ratio, with a prevalence of potentially pathogenic bacteria (e.g., Enterobacteriaceae) and reduction in specific commensals (e.g., Lachnospiraceae), has been described. Structural and functional changes in the intestinal mucosa that contribute to increases in intestinal permeability for bacteria and their products have been observed in patients with liver cirrhosis, which is considered as an important pathogenetic factor for several complications. The mechanism of intestinal barrier dysfunction in cirrhosis is multifactorial, including alcohol, portal hypertension (vascular congestion and dysregulation), endotoxemia, SIBO, local inflammation and, most likely, immunological factors and medications. Key Messages: This review summarizes major achievements regarding intestinal dysfunction in cirrhosis for future gastroenterology research. The question of whether this intestinal barrier dysfunction is accompanied and/or at least partly caused by structural and functional changes in the epithelial tight junction proteins is as yet unsolved. Development of new strategies to modulate gut-liver interaction is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Alterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
The interaction between bacteria and bile
Begley, M., Gahan, C. G. M., & Hill, C. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.09.003 · Cited by 1,790
Prognostic impact of disease-related malnutrition
Norman, K., Pichard, C., Lochs, H., & Pirlich, M. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2007.10.007 · Cited by 1,507
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136
Research works printed but not linked: 16
- 10.1046/j.1440-1746.2002.02877.x · doi:10.1046/j.1440-1746.2002.02877.x
- 10.5754/hge11602 · doi:10.5754/hge11602
- 10.1097/00004836-200302000-00017 · doi:10.1097/00004836-200302000-00017
- 10.1007/BF02996298 · doi:10.1007/bf02996298
- 10.1136/gut.37.4.488 · doi:10.1136/gut.37.4.488
- 10.1111/j.1600-0676.1992.tb00577.x · doi:10.1111/j.1600-0676.1992.tb00577.x
- 10.1016/S0168-8278(05)80127-8 · doi:10.1016/s0168-8278(05)80127-8
- 10.1136/gut.36.5.654 · doi:10.1136/gut.36.5.654
- 10.1096/fj.04-3325fje · doi:10.1096/fj.04-3325fje
- 10.1016/S1091-255X(00)80086-4 · doi:10.1016/s1091-255x(00)80086-4
- 10.1007/s10620-006-9139-8 · doi:10.1007/s10620-006-9139-8
- 10.1097/00042737-200606000-00012 · doi:10.1097/00042737-200606000-00012
- 10.1111/j.1572-0241.2007.01536.x · doi:10.1111/j.1572-0241.2007.01536.x
- 10.1097/MCG.0b013e318038d312 · doi:10.1097/mcg.0b013e318038d312
- 10.1042/bj2100957 · doi:10.1042/bj2100957
- 10.1111/j.1440-1746.1996.tb00325.x · doi:10.1111/j.1440-1746.1996.tb00325.x
Cited by
Items 601–700 of 768
Uchimura, Y., Fuhrer, T., Li, H., Lawson, M. A., Zimmermann, M., Yilmaz, B., Zindel, J., Ronchi, F., Sorribas, M., Hapfelmeier, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.004 · Cited by 153
Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer
Banna, G. L., Torino, F., Marletta, F., Santagati, M., Salemi, R., Cannarozzo, E., Falzone, L., Ferraù, F., & Libra, M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00603 · Cited by 150
Pan, R., Wang, L., Xu, X., Chen, Y., Wang, H., Wang, G., Zhao, J., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14183704 · Cited by 149
Friedman, E. S., Li, Y., Shen, T.-C. D., Jiang, J., Chau, L., Adorini, L., Babakhani, F., Edwards, J., Shapiro, D., Zhao, C., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.022 · Cited by 149
Chin, A. C., Vergnolle, N., MacNaughton, W. K., Wallace, J. L., Hollenberg, M. D., & Buret, A. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1831452100 · Cited by 149
Myelin as a regulator of development of the microbiota-gut-brain axis
Keogh, C. E., Kim, D. H. J., Pusceddu, M. M., Knotts, T. A., Rabasa, G., Sladek, J. A., Hsieh, M. T., Honeycutt, M., Brust-Mascher, I., Barboza, M., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.001 · Cited by 137
De Munck, T. J. I., Xu, P., Verwijs, H. J. A., Masclee, A. A. M., Jonkers, D., Verbeek, J., & Koek, G. H. (2020) · Liver International · doi:10.1111/liv.14696 · Cited by 145
Does consumption of fermented foods modify the human gut microbiota?
Stiemsma, L. T., Nakamura, R. E., Nguyen, J. G., & Michels, K. B. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxaa077 · Cited by 144
Dheer, R., Santaolalla, R., Davies, J. M., Lang, J. K., Phillips, M. C., Pastorini, C., Vazquez-Pertejo, M. T., & Abreu, M. T. (2016) · Infection and Immunity · doi:10.1128/iai.01374-15 · Cited by 144
BELLIKCI-KOYU, E., SARER-YUREKLI, B. P., AKYON, Y., AYDIN-KOSE, F., KARAGOZLU, C., OZGEN, A. G., BRINKMANN, A., NITSCHE, A., ERGUNAY, K., YILMAZ, E., et al. (2019) · Nutrients · doi:10.3390/nu11092089 · Cited by 144
Schokker, D., Zhang, J., Vastenhouw, S. A., Heilig, H. G. H. J., Smidt, H., Rebel, J. M. J., & Smits, M. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116523 · Cited by 142
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Role of the intestinal microbiome, intestinal barrier and psychobiotics in depression
Trzeciak, P., & Herbet, M. (2021) · Nutrients · doi:10.3390/nu13030927 · Cited by 139
Chokshi, N. K., Guner, Y. S., Hunter, C. J., Upperman, J. S., Grishin, A., & Ford, H. R. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2008.01.002 · Cited by 137
Acne, Microbiome, and Probiotics: The Gut–Skin Axis
Sánchez-Pellicer, P., Navarro-Moratalla, L., Núñez-Delegido, E., Ruzafa-Costas, B., Agüera-Santos, J., & Navarro-López, V. (2022) · Microorganisms · doi:10.3390/microorganisms10071303 · Cited by 137
Tedesco, D., Thapa, M., Chin, C. Y., Ge, Y., Gong, M., Li, J., Gumber, S., Speck, P., Elrod, E. J., Burd, E. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.02.019 · Cited by 137
Baars, A., Oosting, A., Knol, J., Garssen, J., & Van Bergenhenegouwen, J. (2015) · Microorganisms · doi:10.3390/microorganisms3040641 · Cited by 135
Prebiotic Effects of Xylooligosaccharides on the Improvement of Microbiota Balance in Human Subjects
Lin, S.-H., Chou, L.-M., Chien, Y.-W., Chang, J.-S., & Lin, C.-I. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/5789232 · Cited by 135
Gut Microbiome and Osteoporosis
Ding, K., Hua, F., & Ding, W. (2020) · Aging and disease · doi:10.14336/ad.2019.0523 · Cited by 134
Knecht, L. D., O'Connor, G., Mittal, R., Liu, X. Z., Daftarian, P., Deo, S. K., & Daunert, S. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.05.037 · Cited by 132
Gastrointestinal dysfunction in liver cirrhosis
Kalaitzakis, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14686 · Cited by 127
Fu, M., Zhang, X., Liang, Y., Lin, S., Qian, W., & Fan, S. (2020) · mBio · doi:10.1128/mbio.03242-19 · Cited by 130
Fukui, H., Xu, X., & Miwa, H. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18071 · Cited by 128
Self-citationBiotic Interactions Shape the Ecological Distributions of Staphylococcus Species
Kastman, E. K., Kamelamela, N., Norville, J. W., Cosetta, C. M., Dutton, R. J., & Wolfe, B. E. (2016) · mBio · doi:10.1128/mbio.01157-16 · Cited by 127
Sung, C. M., Lin, Y.-F., Chen, K.-F., Ke, H.-M., Huang, H.-Y., Gong, Y.-N., Tsai, W.-S., You, J.-F., Lu, M. J., Cheng, H.-T., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.008 · Cited by 127
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Barrow, F., Khan, S., Wang, H., & Revelo, X. S. (2021) · Hepatology · doi:10.1002/hep.31889 · Cited by 126
Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
Quigley, E. M. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.29 · Cited by 125
Manderino, L., Carroll, I., Azcarate-Peril, M. A., Rochette, A., Heinberg, L., Peat, C., Steffen, K., Mitchell, J., & Gunstad, J. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000492 · Cited by 125
Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology
Xie, J., Bruggeman, A., De Nolf, C., Vandendriessche, C., Van Imschoot, G., Van Wonterghem, E., Vereecke, L., & Vandenbroucke, R. E. (2023) · The EMBO Journal · doi:10.15252/embj.2022111515 · Cited by 125
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1020-6 · Cited by 124
Ahmadi, S., Nagpal, R., Wang, S., Gagliano, J., Kitzman, D. W., Soleimanian-Zad, S., Sheikh-Zeinoddin, M., Read, R., & Yadav, H. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.011 · Cited by 124
Reis, D. J., Ilardi, S. S., & Punt, S. E. W. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199041 · Cited by 123
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.073 · Cited by 123
Role of bile acids in inflammatory liver diseases
Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00869-6 · Cited by 121
Hwang, P.-A., Phan, N. N., Lu, W.-J., Hieu, B. T. N., & Lin, Y.-C. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.32033 · Cited by 120
Mahmood, A., FitzGerald, A. J., Marchbank, T., Ntatsaki, E., Murray, D., Ghosh, S., & Playford, R. J. (2007) · Gut · doi:10.1136/gut.2006.099929 · Cited by 119
Arthur, J. C., Gharaibeh, R. Z., Uronis, J. M., Perez-Chanona, E., Sha, W., Tomkovich, S., Mühlbauer, M., Fodor, A. A., & Jobin, C. (2013) · Scientific Reports · doi:10.1038/srep02868 · Cited by 118
Masse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
Microbial involvement in Alzheimer disease development and progression
Bulgart, H. R., Neczypor, E. W., Wold, L. E., & Mackos, A. R. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00378-4 · Cited by 116
Nakjang, S., Ndeh, D. A., Wipat, A., Bolam, D. N., & Hirt, R. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030287 · Cited by 116
Lewis, S. R., Schofield-Robinson, O. J., Alderson, P., & Smith, A. F. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012276.pub2 · Cited by 118
Duytschaever, G., Huys, G., Bekaert, M., Boulanger, L., De Boeck, K., & Vandamme, P. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05933-11 · Cited by 114
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115
Dysfunctional Immune Response in Acute-on-Chronic Liver Failure: It Takes Two to Tango
Martin-Mateos, R., Alvarez-Mon, M., & Albillos, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00973 · Cited by 116
Parmanand, B. A., Kellingray, L., Le Gall, G., Basit, A. W., Fairweather-Tait, S., & Narbad, A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.010 · Cited by 110
Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Shui, L., Yang, X., Li, J., Yi, C., Sun, Q., & Zhu, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02989 · Cited by 115
Alcoholic hepatitis: Translational approaches to develop targeted therapies
Mandrekar, P., Bataller, R., Tsukamoto, H., & Gao, B. (2016) · Hepatology · doi:10.1002/hep.28530 · Cited by 115
Bile acids as key modulators of the brain-Gut-Microbiota axis in alzheimer’s disease
Mulak, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210608 · Cited by 114
Jang, H.-M., Lee, K.-E., Lee, H.-J., & Kim, D.-H. (2018) · Scientific Reports · doi:10.1038/s41598-018-31764-0 · Cited by 116
Monteagudo-Mera, A., Arthur, J. C., Jobin, C., Keku, T., Bruno-Barcena, J. M., & Azcarate-Peril, M. A. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0114 · Cited by 112
Pan, W., Zhao, J., Wu, J., Xu, D., Meng, X., Jiang, P., Shi, H., Ge, X., Yang, X., Hu, M., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01471-8 · Cited by 113
Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut
Ridlon, J. M., Kang, D.-J., Hylemon, P. B., & Bajaj, J. S. (2015) · Digestive Diseases · doi:10.1159/000371678 · Cited by 109
The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder
Młynarska, E., Gadzinowska, J., Tokarek, J., Forycka, J., Szuman, A., Franczyk, B., & Rysz, J. (2022) · Nutrients · doi:10.3390/nu14091921 · Cited by 109
Lee, J., Yang, W., Hostetler, A., Schultz, N., Suckow, M. A., Stewart, K. L., Kim, D. D., & Kim, H. S. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0686-7 · Cited by 107
Enteric dysbiosis is associated with sepsis in patients
Liu, Z., Li, N., Fang, H., Chen, X., Guo, Y., Gong, S., Niu, M., Zhou, H., Jiang, Y., Chang, P., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900398rr · Cited by 107
Wang, Y., Wang, S., Wu, C., Chen, X., Duan, Z., Xu, Q., Jiang, W., Xu, L., Wang, T., Su, L., et al. (2019) · mSystems · doi:10.1128/msystems.00450-19 · Cited by 105
Immune cells in liver regeneration
Li, N., & Hua, J. (2017) · Oncotarget · doi:10.18632/oncotarget.12275 · Cited by 104
Lei, Y., Tang, L., Chen, Q., Wu, L., He, W., Tu, D., Wang, S., Chen, Y., Liu, S., Xie, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34671-1 · Cited by 104
Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome
Jacob, N., Jacobs, J. P., Kumagai, K., Ha, C. W. Y., Kanazawa, Y., Lagishetty, V., Altmayer, K., Hamill, A. M., Von Arx, A., Sartor, R. B., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0055-y · Cited by 102
Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients
Medina, D. A., Pedreros, J. P., Turiel, D., Quezada, N., Pimentel, F., Escalona, A., & Garrido, D. (2017) · PeerJ · doi:10.7717/peerj.3443 · Cited by 101
Decompensated cirrhosis and microbiome interpretation
Bajaj, J. S., Betrapally, N. S., & Gillevet, P. M. (2015) · Nature · doi:10.1038/nature14851 · Cited by 100
Microbiota, a key player in alcoholic liver disease
Cassard, A.-M., & Ciocan, D. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0067 · Cited by 100
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96
Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity—a preliminary report
Liang, Y., Ming, Q., Liang, J., Zhang, Y., Zhang, H., & Shen, T. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0413 · Cited by 95
Gut–kidney crosstalk in septic acute kidney injury
Zhang, J., Ankawi, G., Sun, J., Digvijay, K., Yin, Y., Rosner, M. H., & Ronco, C. (2018) · Critical Care · doi:10.1186/s13054-018-2040-y · Cited by 95
Next generation probiotics for human health: An emerging perspective
Jan, T., Negi, R., Sharma, B., Kumar, S., Singh, S., Rai, A. K., Shreaz, S., Rustagi, S., Chaudhary, N., Kaur, T., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35980 · Cited by 95
Figueroa-Romero, C., Guo, K., Murdock, B. J., Paez-Colasante, X., Bassis, C. M., Mikhail, K. A., Raue, K. D., Evans, M. C., Taubman, G. F., McDermott, A. J., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.041947 · Cited by 94
ALVERDY, J., & AOYS, E. (1991) · Annals of Surgery · doi:10.1097/00000658-199112000-00012 · Cited by 94
Zhao, Y., Qin, G., Sun, Z., Che, D., Bao, N., & Zhang, X. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12128502 · Cited by 94
“ Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier”
Basmaciyan, L., Bon, F., Paradis, T., Lapaquette, P., & Dalle, F. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1612661 · Cited by 89
Han, D., Gao, P., Li, R., Tan, P., Xie, J., Zhang, R., & Li, J. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.07.010 · Cited by 93
Role of Campylobacter jejuni Respiratory Oxidases and Reductases in Host Colonization
Weingarten, R. A., Grimes, J. L., & Olson, J. W. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02261-07 · Cited by 89
Mechanisms of the intestinal and urinary microbiome in kidney stone disease
Miller, A. W., Penniston, K. L., Fitzpatrick, K., Agudelo, J., Tasian, G., & Lange, D. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00647-5 · Cited by 89
Mills, S., Lane, J. A., Smith, G. J., Grimaldi, K. A., Ross, R. P., & Stanton, C. (2019) · Nutrients · doi:10.3390/nu11071468 · Cited by 88
Rai, R. P., Liu, Y., Iyer, S. S., Liu, S., Gupta, B., Desai, C., Kumar, P., Smith, T., Singhi, A. D., Nusrat, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.047 · Cited by 86
Characterization of bacterial isolates from the microbiota of mothers’ breast milk and their infants
Kozak, K., Charbonneau, D., Sanozky-Dawes, R., & Klaenhammer, T. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1103425 · Cited by 86
Oral and Gut Dysbiosis Leads to Functional Alterations in Parkinson’s Disease
Jo, S., Kang, W., Hwang, Y. S., Lee, S. H., Park, K. W., Kim, M. S., Lee, H., Yoon, H. J., Park, Y. K., Chalita, M., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00351-6 · Cited by 85
Svendsen, P., Graversen, J. H., Etzerodt, A., Hager, H., Røge, R., Grønbæk, H., Christensen, E. I., Møller, H. J., Vilstrup, H., & Moestrup, S. K. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.11.004 · Cited by 84
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
Chu, H., Williams, B., & Schnabl, B. (2018) · Liver Research · doi:10.1016/j.livres.2017.11.005 · Cited by 84
Graf, K., Last, A., Gratz, R., Allert, S., Linde, S., Westermann, M., Gröger, M., Mosig, A. S., Gresnigt, M. S., & Hube, B. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039719 · Cited by 83
Acute and repeated exposure to social stress reduces gut microbiota diversity in Syrian hamsters
Partrick, K. A., Chassaing, B., Beach, L. Q., McCann, K. E., Gewirtz, A. T., & Huhman, K. L. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.005 · Cited by 83
Le Morvan de Sequeira, C., Hengstberger, C., Enck, P., & Mack, I. (2022) · Nutrients · doi:10.3390/nu14030621 · Cited by 82
Román, E., Nieto, J. C., Gely, C., Vidal, S., Pozuelo, M., Poca, M., Juárez, C., Guarner, C., Manichanh, C., & Soriano, G. (2019) · Hepatology Communications · doi:10.1002/hep4.1325 · Cited by 80
Matsumoto, M., Ooga, T., Kibe, R., Aiba, Y., Koga, Y., & Benno, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169207 · Cited by 80
Enterobacter bugandensis: a novel enterobacterial species associated with severe clinical infection
Pati, N. B., Doijad, S. P., Schultze, T., Mannala, G. K., Yao, Y., Jaiswal, S., Ryan, D., Suar, M., Gwozdzinski, K., Bunk, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23069-z · Cited by 80
Tsao, S.-P., Nurrahma, B. A., Kumar, R., Wu, C.-H., Yeh, T.-H., Chiu, C.-C., Lee, Y.-P., Liao, Y.-C., Huang, C.-H., Yeh, Y.-T., et al. (2021) · Antioxidants · doi:10.3390/antiox10111823 · Cited by 79
Immunoglobulin A and liver diseases
Inamine, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1400-8 · Cited by 76
The microbiota, the gut and the brain in eating and alcohol use disorders: A ‘Ménage à Trois’?
Temko, J. E., Bouhlal, S., Farokhnia, M., Lee, M. R., Cryan, J. F., & Leggio, L. (2017) · Alcohol and Alcoholism · doi:10.1093/alcalc/agx024 · Cited by 76
Sbahi, H., & Di Palma, J. A. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000087 · Cited by 75
Pataky, Z., Genton, L., Spahr, L., Lazarevic, V., Terraz, S., Gaïa, N., Rubbia-Brandt, L., Golay, A., Schrenzel, J., & Pichard, C. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4179-1 · Cited by 75
Kortman, G. A. M., Dutilh, B. E., Maathuis, A. J. H., Engelke, U. F., Boekhorst, J., Keegan, K. P., Nielsen, F. G. G., Betley, J., Weir, J. C., Kingsbury, Z., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01481 · Cited by 73
A preliminary study of gut microbiome variation and HPA axis reactivity in healthy infants
Rosin, S., Xia, K., Azcarate-Peril, M. A., Carlson, A. L., Propper, C. B., Thompson, A. L., Grewen, K., & Knickmeyer, R. C. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.105046 · Cited by 74
van der Lugt, B., Rusli, F., Lute, C., Lamprakis, A., Salazar, E., Boekschoten, M. V., Hooiveld, G. J., Müller, M., Vervoort, J., Kersten, S., et al. (2018) · Aging · doi:10.18632/aging.101439 · Cited by 72
Chen, J., Wei, Y., He, J., Cui, G., Zhu, Y., Lu, C., Ding, Y., Xue, R., Bai, L., Uede, T., et al. (2014) · Scientific Reports · doi:10.1038/srep07259 · Cited by 71
Bacterially produced metabolites protect C. elegans neurons from degeneration
Urrutia, A., García-Angulo, V. A., Fuentes, A., Caneo, M., Legüe, M., Urquiza, S., Delgado, S. E., Ugalde, J., Burdisso, P., & Calixto, A. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000638 · Cited by 71
Publisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
Wirth, R., Bódi, N., Maróti, G., Bagyánszki, M., Talapka, P., Fekete, É., Bagi, Z., & Kovács, K. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110440 · Cited by 69
The immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
Davis, S. C., Yadav, J. S., Barrow, S. D., & Robertson, B. K. (2017) · MicrobiologyOpen · doi:10.1002/mbo3.476 · Cited by 69
Alcohol-associated bowel disease: new insights into pathogenesis
Maccioni, L., Fu, Y., Horsmans, Y., Leclercq, I., Stärkel, P., Kunos, G., & Gao, B. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100013 · Cited by 69
Metadata
- Authors
- Fukui, H., & Wiest, R.
- Venue
- Inflammatory Intestinal Diseases
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 1
- Issue
- 1
- Pages
- 24-40
- ISSN
- 2296-9365 (ISSN-L)
- 2296-9403
- OpenAlex
- W2328023807
- Cited by
- 6,808
- References
- 200
- FWCI
- 440.60
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.